Brightstone Venture Capital


Brightstone Venture Capital manages a $100 million venture fund focused on early-growth stage investments. The firm invests primarily in Technology and Life Sciences sectors and leverages the operating experience and investment background of its partners to support portfolio companies.

Industries

augmented-reality
biotechnology
data-storage
enterprise-software
fintech-e067
health-diagnostics
life-science
medical-device
semiconductor

Nr. of Employees

small (1-50)

Brightstone Venture Capital

510 First Ave N, Suite #200, Minneapolis, MN 55403


Portfolio

Recently raised $80M in a Series D funding.

#Virtual reality / social VR

Company completed an IPO on NASDAQ (CELC).

#Cellular diagnostics / personalized medicine

$321 million sale to WAITR Holdings (NASDAQ WTRH).

#Food delivery / logistics marketplace

Provides iPS-based micro-organ platforms for drug toxicity and efficacy testing; IPO on NASDAQ (VYNT).

#Stem cell technologies / drug testing platforms

Described as a cloud storage platform; recently raised $112M in a Series C funding.

#Cloud storage / infrastructure

Delivers SSD controllers with host-based FTL and Ethernet I/O; recently raised $10M in a Series G funding.

#Semiconductor / SSD controller IP

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.